Cholera is a bacterial disease characterised by profuse watery diarrhoea. It is caused by the toxin producing forms of the bacteria Vibrio cholera. These forms (serogroups) include V. cholerae O1 and V. cholerae O139. It is usually contracted by ingesting contaminated water or food, with humans as the only known natural hosts. Cholera is common in many low-income countries and is usually associated with poverty, poor sanitation and poor access to clean drinking water.

The overall risk of cholera for travellers is extremely low. Activities that may increase risk of infection include drinking untreated water or eating poorly cooked seafood in areas where outbreaks are occurring. Travellers living in unsanitary conditions, for example relief workers in disaster or refugee areas, are also at risk.

Symptoms of cholera include: sudden onset of profuse, watery diarrhoea with associated nausea and vomiting. If untreated, cholera can rapidly lead to serious dehydration, dangerous salt imbalances and shock. Over 50 percent of the most severely affected patients die within a few hours. With prompt, effective treatment, mortality is less than one percent. Cholera may be mild or occur without symptoms in healthy individuals.


The risk of acquiring cholera can be reduced by ensuring good personal hygiene and following guidelines on prevention of food and water-borne diseases.

Cholera vaccine

An oral, inactivated cholera vaccine, Dukoral®, is available in the UK. This vaccine is effective against V. cholerae serogroup O1. This vaccine is not indicated for most travellers, but is recommended for those whose activities or medical history put them at increased risk. This includes:

  • aid workers
  • those going to areas of cholera outbreaks who have limited access to safe water and medical care.
  • those for whom vaccination is considered potentially beneficial. (i.e. for those who do not fit into the above groups, but are still considered at higher risk)



The National Travel Health Network and Centre (NaTHNaC) is commissioned by Public Health England to provide health information for both healthcare professionals and travellers. Information is compiled by the NaTHNaC clinical and scientific team, and updated regularly. Further advice on health risks and disease outbreaks is available at

Date last reviewed: November 2015

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.